Nour Sherif G
Interventional MRI Program, Emory University Hospitals and School of Medicine, Atlanta, Georgia; Divisions of Abdominal Imaging, Interventional Radiology, and Image-Guided Medicine, Emory University Hospitals and School of Medicine, Atlanta, Georgia.
Semin Intervent Radiol. 2016 Sep;33(3):206-16. doi: 10.1055/s-0036-1586153.
Prostate cancer is the most common cancer (other than skin cancer) in American men, with one in seven men being diagnosed with this disease during his lifetime. The estimated number of new prostate cancer cases in 2016 is 180,890. For the first time, imaging has become the center of the search for contained, intraglandular, small-volume, and unifocal disease, and an increasing number of academic institutions as well as private practices are implementing programs for prostate multiplanar magnetic resonance imaging (MRI) as parts of their routine offerings. This article reviews the role of MRI-guided focal prostate ablation, as well as opportunities for further growth in this minimally invasive therapy of prostate cancer.
前列腺癌是美国男性中最常见的癌症(皮肤癌除外),七分之一的男性在其一生中会被诊断出患有这种疾病。2016年前列腺癌新发病例估计为180,890例。成像首次成为寻找局限于腺体内、小体积和单灶性疾病的核心,越来越多的学术机构以及私人诊所正在实施前列腺多平面磁共振成像(MRI)计划,作为其常规服务的一部分。本文综述了MRI引导下聚焦前列腺消融的作用,以及这种前列腺癌微创治疗进一步发展的机会。